Int J Clin Oncol 2017 Nov 13

Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib.

Eskazan AE1.
href="/pubmed/?term=Eskazan%20AE%5BAuthor%5D&cauthor=true&cauthor_uid=29134363">Eskazan AE¹.

1: Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey. emreeskazan@hotmail.com.

Share

PubMed Commons home
PubMed Commons

0 comments

How to join PubMed Commons
How to cite this comment:

Supplemental Content

Full text links

29134363[uid]
See more...

You are here: NCBI > Literature > PubMed
Support Center

PubMed Commons